Back to search

Article

Non-cell autonomous cardiomyocyte regulation complicates gene supplementation therapy for <i>LMNA</i> cardiomyopathy

2023-07-18

Abstract excerpt

<h4>Aims</h4> Recombinant adeno-associated viruses (rAAVs) are federally approved gene delivery vectors for in vivo gene supplementation therapy. Loss-of-function truncating variants of LMNA , the coding gene for Lamin-A/C, are one of the primary causes of inherited dilate cardiomyopathy (DCM). Here we aim to study whether AAV-based LMNA supplementation could treat LMNA deficiency-triggered cardiac defects. <...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b44d7110-43a4-5674-8d07-cbc2588b4788
DOI
10.1101/2023.07.18.549413
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Non-cell autonomous cardiomyocyte regulation complicates gene supplementation therapy for <i>LMNA</i> cardiomyopathyDOI 10.1101/2023.07.18.549413
Select a neighboring publication to make it the new centre.